Literature DB >> 24918597

Lessons learned from HPV vaccine delivery in low-resource settings and opportunities for HIV prevention, treatment, and care among adolescents.

Vivien D Tsu1, Tania Cernuschi, D Scott LaMontagne.   

Abstract

BACKGROUND: Human papillomavirus (HPV) vaccines to prevent cervical cancer have become available in recent years and presented a new challenge to health systems, since they prevent a sexually transmitted virus and are most effective if they are delivered to young adolescent girls, a group not widely served by other health programs. Demonstration and pilot HPV vaccination programs undertaken in the past 7-8 years in low-resource settings have produced lessons that may be more broadly applied to other adolescent health interventions, particularly to those that attempt to reduce human immunodeficiency virus (HIV) infection.
METHODS: A systematic literature review was undertaken to identify formal and informal evaluations of HPV vaccine use in low- and middle-income countries. Special attention was devoted to the detailed evaluations carried out on large demonstration projects in India, Peru, Uganda, and Vietnam.
RESULTS: These lessons fall into 2 main categories: service delivery operations and community outreach and mobilization. Operational issues included venue and timing of vaccinations, definition of target population, micro-planning and coordination, integration with other services, and training. Community issues included consent, messages and channels, endorsement and support, and timing of mobilization efforts. DISCUSSION: Careful planning, good coordination across sectors and levels, and sensitive attention to the expressed needs for information and preferences for communication channels among youth, parents, and communities more broadly were among the key lessons that are relevant for HIV interventions, but many of the smaller details were also important.
CONCLUSIONS: Applying or adapting these lessons to adolescent HIV services could accelerate effective program design and enhance success.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24918597     DOI: 10.1097/QAI.0000000000000175

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  10 in total

Review 1.  HPV Vaccination: An Underused Strategy for the Prevention of Cancer.

Authors:  Gilla K Shapiro
Journal:  Curr Oncol       Date:  2022-05-23       Impact factor: 3.109

2.  Knowledge and Attitudes Towards Human Papillomavirus (HPV) Among Academic and Community Physicians in Mangalore, India.

Authors:  Chelsea Canon; Valery Effoe; Veena Shetty; Avinash K Shetty
Journal:  J Cancer Educ       Date:  2017-06       Impact factor: 2.037

Review 3.  Learning lessons from operational research in infectious diseases: can the same model be used for noncommunicable diseases in developing countries?

Authors:  William K Bosu
Journal:  Adv Med Educ Pract       Date:  2014-12-04

4.  Applying the results based management framework to the CERCA multi-component project in adolescent sexual and reproductive health: a retrospective analysis.

Authors:  Kathya Cordova-Pozo; Andrea J Hoopes; Freddy Cordova; Bernardo Vega; Zoyla Segura; Arnold Hagens
Journal:  Reprod Health       Date:  2018-02-08       Impact factor: 3.223

Review 5.  [Human papillomavirus vaccine receptivity: a systematic reviewReceptividad con respecto a la vacuna contra el virus del papiloma humano: revisión sistemática].

Authors:  Lídia Ester Lopes da Silva; Maria Liz Cunha de Oliveira; Dayani Galato
Journal:  Rev Panam Salud Publica       Date:  2019-02-06

6.  Mobilize to vaccinate: lessons learned from social mobilization for immunization in low and middle-income countries.

Authors:  Mohamed F Jalloh; Elisabeth Wilhelm; Neetu Abad; Dimitri Prybylski
Journal:  Hum Vaccin Immunother       Date:  2019-10-29       Impact factor: 3.452

7.  Human Papillomavirus Prevalence and Vaccination Rates Among Users of Pre-Exposure Prophylaxis for Human Immunodeficiency Virus Prevention.

Authors:  Paul Rotert; Christopher Wheldon; Jenn Kownack; Zoe Sullivan-Blum; Brendan Cokingtin; Karishma Khetani; Kavindu Ndeti; Kevin Skyes; Megha Ramaswamy
Journal:  J Prim Care Community Health       Date:  2022 Jan-Dec

Review 8.  A Framework for Cervical Cancer Elimination in Low-and-Middle-Income Countries: A Scoping Review and Roadmap for Interventions and Research Priorities.

Authors:  Michelle B Shin; Gui Liu; Nelly Mugo; Patricia J Garcia; Darcy W Rao; Cara J Bayer; Linda O Eckert; Leeya F Pinder; Judith N Wasserheit; Ruanne V Barnabas
Journal:  Front Public Health       Date:  2021-07-01

Review 9.  Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective.

Authors:  Sarah Finocchario-Kessler; Catherine Wexler; May Maloba; Natabhona Mabachi; Florence Ndikum-Moffor; Elizabeth Bukusi
Journal:  BMC Womens Health       Date:  2016-06-04       Impact factor: 2.809

10.  Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries.

Authors:  Katherine E Gallagher; Natasha Howard; Severin Kabakama; Sandra Mounier-Jack; Ulla K Griffiths; Marta Feletto; Helen E D Burchett; D Scott LaMontagne; Deborah Watson-Jones
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.